Clinical Trial: Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07569315) titled 'Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders' on April 29.

Brief Summary: The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Infertility

Intervention: DRUG: Successive doses GnRH agonist

GnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) is administered 3...